title: Analysis method and experimental conditions affect computed circadian phase from melatonin data.
abstract: Accurate determination of circadian phase is necessary for research and clinical purposes because of the influence of the master circadian pacemaker on multiple physiologic functions. Melatonin is presently the most accurate marker of the activity of the human circadian pacemaker. Current methods of analyzing the plasma melatonin rhythm can be grouped into three categories: curve-fitting, threshold-based and physiologically-based linear differential equations. To determine which method provides the most accurate assessment of circadian phase, we compared the ability to fit the data and the variability of phase estimates for seventeen different markers of melatonin phase derived from these methodological categories. We used data from three experimental conditions under which circadian rhythms - and therefore calculated melatonin phase - were expected to remain constant or progress uniformly. Melatonin profiles from older subjects and subjects with lower melatonin amplitude were less likely to be fit by all analysis methods. When circadian drift over multiple study days was algebraically removed, there were no significant differences between analysis methods of melatonin onsets (P = 0.57), but there were significant differences between those of melatonin offsets (P<0.0001). For a subset of phase assessment methods, we also examined the effects of data loss on variability of phase estimates by systematically removing data in 2-hour segments. Data loss near onset of melatonin secretion differentially affected phase estimates from the methods, with some methods incorrectly assigning phases too early while other methods assigning phases too late; missing data at other times did not affect analyses of the melatonin profile. We conclude that melatonin data set characteristics, including amplitude and completeness of data collection, differentially affect the results depending on the melatonin analysis method used.
authors.affiliation: Division of Sleep Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America. ebklerman@hms.harvard.edu
authors.forename: Hadassa
authors.initials: H
authors.lastname: Klerman
authors.forename: Melissa A
authors.initials: MA
authors.lastname: St Hilaire
authors.forename: Richard E
authors.initials: RE
authors.lastname: Kronauer
authors.forename: Joshua J
authors.initials: JJ
authors.lastname: Gooley
authors.forename: Claude
authors.initials: C
authors.lastname: Gronfier
authors.forename: Joseph T
authors.initials: JT
authors.lastname: Hull
authors.forename: Steven W
authors.initials: SW
authors.lastname: Lockley
authors.forename: Nayantara
authors.initials: N
authors.lastname: Santhi
authors.forename: Wei
authors.initials: W
authors.lastname: Wang
authors.forename: Elizabeth B
authors.initials: EB
authors.lastname: Klerman
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D002940:Circadian Rhythm; D056925:Circadian Rhythm Signaling Peptides and Proteins / Q000378:metabolism*; D006801:Humans; D008550:Melatonin / Q000097:blood*; D008875:Middle Aged; D008954:Models, Biological
chemical_list: D015415:Biomarkers; D056925:Circadian Rhythm Signaling Peptides and Proteins; D008550:Melatonin